| Old Articles: <Older 25871-25880 Newer> |
 |
The Motley Fool August 31, 2007 David Lee Smith |
Dubious Numbers for Tribune Will the Tribune privatization deal with Chicago billionaire Sam Zell really ever happen at the agreed-to price? The main difficulty for Tribune is a sharp and continuing slide in advertising revenue.  |
The Motley Fool August 31, 2007 Ryan Fuhrmann |
Is Jack Daniel's Tasty? Brown-Forman, owner of the venerable Jack Daniel's whiskey brand, is a profitable spirits firm, but is this enough to justify its lofty valuation?  |
The Motley Fool August 31, 2007 Markos Kaminis |
Smithfield Foods' Shanghai Surprise During their earnings conference call, Smithfield Foods officially announced a deal with an "undisclosed" trading company in China to deliver them sixty million pounds of pork. It's a modest deal, but it represents a foot in the doorway of the hugely important Chinese market.  |
The Motley Fool August 31, 2007 Ryan Fuhrmann |
Benihana Is On a Sushi Roll Japanese-themed restaurateur Benihana reports another quarter of increased sales and existing store gains. If management can effectively balance older-store renovations with new-store ambitions, investors may want to consider Benihana for some restaurant exposure in their portfolios.  |
The Motley Fool August 31, 2007 Lawrence A. Rothman |
Restoration Hardware: Too Much Red Quarterly results didn't meet expectations at Restoration Hardware, which sells high-end home-furnishings. The housing slowdown and poor merchandising hasn't helped the company; neither has the large debt they carry.  |
The Motley Fool August 31, 2007 David Lee Smith |
Cement Your Stock Returns With housing's recovery still uncertain, two cement stocks merit investigation. Investors, look at Mexico-based Cemex, and its Dallas-based counterpart Texas Industries, two companies that can benefit from a turn in the housing market when it occurs.  |
The Motley Fool August 31, 2007 Brian Orelli |
A Stem-Cell Primer Public funding from states could help companies doing stem cell research. Read about Geron, StemCells, Osiris Therapeutics, ViaCell and Invitrogen, companies that may profit from the increased public spending.  |
The Motley Fool August 31, 2007 David Lee Smith |
Builders to the Junkyard? The next step in housing's multi-phase crisis could be downgrading the builders to junk status. Several big building stocks, including Lennar, Centex, and Pulte, are currently being scrutinized by Moody's.  |
The Motley Fool August 31, 2007 David Lee Smith |
Bring On the Drillers' Bounce Take a closer look at why drilling stocks, such as Transocean, Diamond Offshore, and Ensco, all trade at a distinct discount to the general markets. It all has to do with their cyclicality charge.  |
The Motley Fool August 31, 2007 Rich Smith |
Get to Know a Guru Analyst Kevin Dann and his firm of the same name have made bold claims of their trading skills and acumen, but their record has not lived up to that. Take a closer look at one of his recent recommendations, AutoZone. Is he on target this time?  |
| <Older 25871-25880 Newer> Return to current articles. |